The goal of the project is to develop novel approaches that strengthen and reduce the costs of domestic mAb biomanufacturing to protect against and treat infection by filoviruses.
LanzaTech Global, Inc. (NASDAQ: LNZA), a leader in industrial carbon recycling, is thrilled to announce the awarding of a €40 million grant from the European Union’s Innovation Fund, subject to the ...
After a prolonged downturn lasting nearly four years, the biotechnology industry is showing clear signs of recovery. Taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback